Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half and full year ending June 30, 2022. For the first half of fiscal 2022, the company expects net sales of ?76,800 million, Operating income of ?3,100 million and Net income attributable to owners of parent of ?2,260 million or ?148.91 per share. For the year ending June 30, 2022, the company expects net sales of ?160,000 million, Operating income of ?6,500 million and Net income attributable to owners of parent of ?4,720 million or ?310.99 per share.